An epidemiologic study of multiple sclerosis in Northern Ireland

Neurology

Volumn 50, Issue 2, 1998, Pages 423-428

  McDonnell, G V ^a   Hawkins, S A ^a,b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; IRELAND; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PREVALENCE; PRIORITY JOURNAL;

EID: 0031884920     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.2.423     Document Type: Article

References (32)

1. Marytn CN. The epidemiology of multiple sclerosis. In: Matthews WB, ed. McAlpine's multiple sclerosis. Edinburgh: Churchill Livingstone, 1991:3-40.
2. Poskanzer DC, Prenney LB, Sheridan JL, YonKondy J. Multiple sclerosis in the Orkney and Shetland Islands. 1. Epidemiology, clinical factors and methodology. J Epidemiol Community Health 1980;34:229-239.
3. Phadke JG, Downie AW. Epidemiology of multiple sclerosis in the north-east (Grampian Region) of Scotland-an update. J Epidemiol Community Health 1987;41:5-13.
4. Williams ES, McKeran RO. Prevalence of multiple sclerosis in a south London borough. BMJ 1986;293:237-239.
5. Roberts MHW, Martin JP, McLellan DL, Mclntosh-Michaelis SA, Spackman AJ. The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority. J Neurol Neurosurg Psychiatry 1991;54:55-59.
6. Mumford CJ, Fraser MB, Wood NW, Compston DAS. Multiple sclerosis in the Cambridge health district of East Anglia. J Neurol Neurosurg Psychiatry 1992;55:877-882.
7. Rice-Oxley M, Williams ES, Rees JE. A prevalence survey of multiple sclerosis in Sussex. J Neurol Neurosurg Psychiatry 1995;58:27-30.
8. Robertson N, Deans J, Fraser M, Compston DAS. Multiple sclerosis in the north Cambridgeshire districts of East Anglia. J Neurol Neurosurg Psychiatry 1995;59:71-76.
9. Allison RS, Millar JHD. Prevalence and familial incidence of disseminated sclerosis (A report to the Northern Ireland Hospitals Authority on the results of a three-year survey). Ulster Med J 1954;23(suppl 2):5-27.
10. Millar JHD. Multiple sclerosis in Northern Ireland. In: Clifford Rose F, éd. Clinical epidemiology. Tunbridge Wells: Pitman Medical, 1980:222-227.
11. Hawkins SA, Kee F. Updated epidemiological studies of multiple sclerosis in Northern Ireland. J Neurol 1988;235:S86.
12. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
13. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
14. Kurtzke JF. A proposal for a uniform minimal record of disability in multiple sclerosis. Acta Neurol Scand 1981;64(suppl 87):110-129.
15. Mellerup E, Fog T, Raun N, et al. The socio-economic scale. Acta Neurol Scand 1981;64(suppl 87):130-138.
16. Robertson N, Compston A. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1995;58: 2-6.
17. Swingler RJ, Compston DAS. The prevalence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 1988;51:1520-1524.
18. Hennessy A, Swingler RJ, Compston DAS. The incidence and mortality of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 1989;52:1085-1089.
19. Lockyer MJ. Prevalence of multiple sclerosis in five rural Suffolk practices. BMJ 1991;303:347-348.
20. Sharpe G, Price SE, Last A, Thompson RJ. Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey. J Neurol Neurosurg Psychiatry 1995;58:22-26.
21. Rodriguez M, Siva A, Ward J, Stolp-Smith K, O'Brien P, Kurland L. Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota. Neurology 1994;44:28-33.
22. Shepherd DI, Summers A. Prevalence of multiple sclerosis in Rochdale. J Neurol Neurosurg Psychiatry 1996;61:415-417.
23. Panelius M. Studies on epidemiological, clinical and etiological aspects of multiple sclerosis. Acta Neurol Scand 196945(suppl 39):l-82.
24. Minderhoud JM, van der Hoeven JH, Prange AJA. Course and prognosis of chronic progressive multiple sclerosis. Acta Neurol Scand 1988;78:10-15.
25. Shepherd DI. Clinical features of multiple sclerosis in northeast Scotland. Acta Neurol Scand 1979;60:218-230.
26. Confavreux C, Aimard G, Dévie M. Course and prognosis of multiple sclerosis assessed by the computerised data processing of 349 patients. Brain 1980;103:281-300.
27. Noseworthy J, Paty D, Wonnacott T, Feasby T, Ebers G. Multiple sclerosis after age 50. Neurology 1983;33:1537-1544.
28. van Lambalgen RV, Sanders EACM, D'Amaro J. Sex distribution, age of onset and HLA profiles in two types of multiple sclerosis: a role for sex'hormones and microbial infections in the development of autoimmunity. J Neurol Sci 1986;76:13-21.
29. Larsen JP, Kvaale G, Rase T, Nyland H, Aarli JA. Multiple sclerosis-more than one disease? Acta Neurol Scand 1985;72: 145-150.
30. Poser S, Wikstrom J, Bauer HJ. Clinical data and the identification of special forms of multiple sclerosis: 1271 cases stud-, ied with a standardised documentation system. J Neurol Sci 1979;40:159-168.
31. Hutchinson M. Disability due to multiple sclerosis: a community-based study of an Irish county. Ir Med J 1986;79: 48-50.
32. Lublin FD, Reingold SC, for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911.